Loading...

Major Indexes

Free Cash Flow

Array BioPharma Inc.

Array BioPharma Inc. (ARRY)

$46.57
17.69 (+61.25%)

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 69.5842.0851.90137.87150.84173.75234.24315.77425.69573.88773.65
Revenue (%)
Operating Cash Flow -87.07-71.68-5.79-70.09-39.40-119.79-176.68-238.19-321.10-432.88-583.56
Operating Cash Flow (%)
Capital Expenditure 2.342.612.513.163.511.237.7110.3914.0118.8825.45
Capital Expenditure (%)
Free Cash Flow -84.73-69.07-3.29-66.93-35.88-118.55-168.98-227.80-307.10-414.00-558.11

FCF Unlevered from cash flow statement